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1. Introduction 
Luteinizing hormone (LH) consists of 2 chemical- 
ly dissimilar subunits, 01 and fl (LHa and LH@. While 
our work on the structure of bovine luteinizing 
hormone subunit (B-LH@) was in progress, complete 
amino acid sequences for ovine LyB (0-LHP) were 
independently presented by Liu et al. [l] and by 
Papkoff et al. [2] . Our work being now complete, 
it is now possible to determine the extent of simi- 
larity between ovine and bovine sequences. This 
task is complicated by discrepancies appearing in the 
ovine sequences presented by the other two groups. 
Our previous data concerning the structure of bovine 
LHa chain (B-LHa) have focused attention on 
sequence variability, particularly obvious around 
the carbohydrate attachment sites [3]. We have 
looked for such a phenomenon in B-LH/3 and com- 
pared the composition of its polysaccharide unit to 
that of the ovine molecule. 
2. Experimental 
2.1. Methods 
B-LH/3 was prepared as described [3]. The methods 
used for amino acid and sugar analyses, reduction 
and alkylation with iodoacetic acid of the protein, 
cyanogen bromide cleavage, tryptic hydrolysis, end 
group analyses and sequence determinations were 
also described [3] . The chymotryptic digestions 
were carried out at pH 8.5 in 0.2 M sodium phos- 
phate buffer for 2 hr at 37”, with a weight ratio of 
North-Holland Publishing Company - Amsterdam 
enzyme to peptide of 1: 100. Maleylation of lysine 
residues was performed at pH 9.4 in a borate buffer 
[4]. The various digests were fractionated by chrom- 
atographic procedures, i.e. gel-filtration on Biogel 
P6 (Calbiochem) and on Sephadex G-25, G-l 5 (fine, 
Pharmacia) and ion exchange chromatography on 
SE- or QAE-Sephadex (C25 and A25, Pharmacia) 
[3] . Further purification of peptides were done by 
electrophoresis at 75 V/cm on Whatman 3 MM paper 
using pyridine-acetate buffer at pH 3.7 (pyridine - 
99% acetic acid - water, 3:20:77). 
The cyanogen bromide fragments were separated 
on a 2 m column of Sephadex G-50 (fine, Pharmacia). 
The largest tryptic peptide from the maleylated pro- 
tein (MT,) was obtained by the same gel-filtration 
procedure. 
2.2. Nomenclature 
Ti indicates tryptic peptides; MT,, tryptic pep 
tides resulting from trypsin digestion of the maleyl- 
ated protein; TiCi, peptides resulting from chymo- 
trypsin digestion of tryptic (Ti) peptides; CNBr, 
the cyanogen bromide fragments individualized by 
roman numerals. 
3. Results and discussion 
The amino acid sequence, as indicated in fig. 1, 
was established by sequential degradation of the 
various tryptic peptides, whose compositions are 
given in table 1. Ordering the sequence resulted from 
the determination of the composition (table 2) and 
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Fig. 1. The amlnc+a A sequence of bovine LHfi. 
amino terminal sequence of the 4 CNBr peptides, 
together with the characterization of MT2, the largest 
tryptic peptide resulting from the digestion of the 
maieylated protein (table 2). The identification of 
T, YC a b:o~ke:l amino terminal dipeptide was estab- 
lished after its isolation from a iryptic digest of 
CNBR 1. The nature of the group blocking the 
amino terminus was not determined. 
Taking into account the modifications of Ward 
and Liu [.5] to their preliminary data [l] , a single 
point of dissimilarity is demonstrated when com- 
paring the ovine and the bovine sequences. Instead 
of the 50-53 sequence, Pro-Pro-Pro-Met in the 
ovine chain, the corresponding portion of the bovine 
molecule is shortened by one proline residue. Note- 
worthy is that Ward and Liu [5] have assigned all 
amide or acid forms for the asparaginyl and gluta- 
minyl residues in the ovine sequence, a precision 
lacking in our study. In addition, the 89-92 
sequence has not been determined for the bovine 
molecule. 
Both sequences (ours on B-LH/3 and that of Ward 
and Liu [5] on 0-LHP) differ by 20 positions com- 
pared to that proposed by Parkoff et al. [2] for 
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Table 1. 
Tryptic peptide compositions*. 
December 1971 
Amino T l T2 T2b** T3 T3Ca T3Cb T3Cc T3Cd T4 
acid 
Lys 0.9 (1) 0.9 (1) 0.9 (1) 1.1 (1) 0.9 (1) 
His 
Arg t.0 (1) 0.9 (1) 1.0 (1) 
CM-Cys 1.1 (1) 0.6 (1) 3.6 (4) 1.6 (2) 2.2*** (2) 1.1 (1) 1.1 (1) 
Asp 1.0 (1) 1.1 (1) 
Thr 0.9 (1) 0.9 (1) 2.6 (3) 1.0 (1) 1.9 (2) 1.9 (2) 
Ser 1.0 (1) 1.6 (2) 1.9 (2) 1.0 (1) 0.7 (1) 
Glu 1.9 (2) 2.0 (2) 1.2 (1) 1.0 (1) 
Pro 2.8 (3) 1.0 (1) 1.6 (2) 1.2 (1) 1.1 (1) 1.1 (1) 
Gly 1.0 (1) 1.0 (1) 1.2 (1) 1.0 (1) 
Ala 2.9 (3) 2.9 (3) 1.8 (2) 1.0 (1) 0.9 (1) 1.0 (t)  
Val 1.0 (1), 1.0 (1) 
Met 0.8 (1) 1.1 (1) 0.8 (1) 
lie 0.9 (1) 0.9 (1) 1.6 (2) 1.0 (1) 0.9 (1) 0.9 (1) 
Leu 2.7 (3) 1.0 (1) 
Tyr 0.6 (1) 0.6 (1) 0.7 (1) 
Phe 0.9 (1) 0.7 (1) 
Sugars Present Present 
Table 1 (Cont'd) 
Amino T s T 6 T7 Tsa** T8 b T9 TlO TloC a TloCb 
acid 
Lys 
His 
Arg 1.0 (1) 
CM-Cys 
Asp 
Thr 
Set 
Glu 1.0 (1) 
Pro 3.6 (4) 
Gly 
Ala 
Val 1.6 (2) 
Met 0.8 (1) 
lle 0.6 (1) 
Leu 1.9 (2) 
Tyr 
Phe 
Sugars 
0.8 (1) 1.3 0.9 (1) 0.9 (1) 
0.9 (1) 1.0 (1) 0,9 0.8 (1) 
1.0 (1) 0.8 (1) 2.6 1.0 (I) 0.7 (1) 1.0 (1) 
1.0 (1) 1.3 1.0 (1) 1.9 (1) 1.9 (2) 
0.9 (1) 0.9 (1) 0.8 (1) 0.9 (1) 
0.9 (1) 1.6 1.7 (2) 
1.1 (1) 1.0 (1) 1.0 (1) 
3.5 (4) 6.7 1.1 (1) 4.0 (4) 1.0 (1) 3.0 (3) 
1.6 (2) 2.9 1.8 (2) 
1.1 (1) 1.3 1.0 (1) L0 (1) 
L0 (1) 1.1 (1) 0.8 (1) 2.6 
0.9 (1) 1.0 
1.0 (1) 
0.9 (1) 
0.2 0.2 
0.7 (1) 2.3 1.0 (1) 2.0 1.0 (1) 1.1 
1.0 (1) 0.8 
* Data expressed as molar ratios of the various amino acids. The numbers in parentheses are theoretical values. Hydrolysis 
time was 24 hr. No correction for destruction during hydrolysis was made. 
** Peptide resulting from a non-specific leavage. 
*** Mercaptoacetic a id added for the hydrolysis [7]. 
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Table 2 
December 1971 
Amino MT2 composition* Cyanogen bromide peptide compositions* 
acid CNBr 1 CNBr II CNBr III CNBr IV 
Lys 2.0 0.9 (1) 0.8 (1) 
His 0.4 (1) 1.2 (2) 
Arg 1.3"* 2.1 (2) 1.4 (1) 1.4 (3) 1.9 (2) 
CM-Cys 5.1 *** 3.6 (5) 1.8 (2) 4.7 (5) 
Asp 1.0 1.6 (1) 1.2 (1) 3.2 (3) 
Thr 3.8 3.4 (4) 0.6 (1) 2.3 (2) 
Ser 1.9 2.8 (3) 1.3 (1) 3.4 (4) 
Glu 3.1 3.2 (3) 1.8 (2) 1.3 (1) 
Pro 4.7** 5.0 (5) 2.9 (3) 5.0 (5) 5.7 (7) 
Gly 1.5"* 2.0 (2) 2.1 (2) 3.1 (3) 
Ala 4.9 4.5 (5) 0.7 (1) 2.2 (2) 
Val 1.2 1.3 (1) 1.9 (2) 2.7 (3) 2.2 (2) 
Met 0.9 0.8 (1) 1.0 (1) 0.9 (1) 
lie 2.6 2.4 (3) 0.6 (1) 0.4 (0-1) 
Leu 2.6** 3.4 (3) 2.1 (2) 2.0 (2) 4.13 (4-5) 
Tyr 0.6 0.9 (1) 0.4 (1) 
Phe 1.0 0.9 (1) 0.5 (1) 0.9 (1) 
Sugars Present Present 
* Data expressed as molar ratios of the various amino acids. The numbers in parentheses are theoretical values. Hydrolysis 
time was 24 hr. No correction for destruction during hydrolysis was made. 
** Non-integrality due to partial cleavage between 5 and 6 positions. 
*** Mercaptoacetic a id added for the hydrolysis [7]. 
Table 3 
Sugar compositions. 
Residue B-LHI3 T2 T2b O-LH*/3 
Fucose 0.9 1.0 1.0 0.9 
Mannose 3.5 3.5 3.8 2.0 
Galactose 0 0 0 0.5 
Glucosamine 2.8 2.6 2.9 2.9 
Galactosamine 1.8 1.5 1.7 0.9 
Composition of B-LH# is expressed after correction of the 
results for 100% recovery and for a molecular weight of 
t5,000 for the subunit. The values for the sugars of the 
glycopeptides are expressed as residues per residue of aspartic 
acid. 
* from reference 16]. 
O-LH/3. Ward and Liu [5] have described a sequence 
hetecogeneity at the carboxy terminus of O-LHfl. In 
our hands, a 4 hr digestion with carboxypeptidase 
A of  the carboxy-terminal bovine peptide, T~o, 
yielded 0.17 #mole /mg of isoleucine and 0.1 #mole of 
leucine. The kinetic study of  this digestion together 
with the amino acid composit ion of T~o also suggest 
a variability in the length of  B-LHfl with a major 
port ion of  the chain populat ion ending with Asx-OH, 
but the sequences Asx- l le -OH and Asx - I le -Leu-OH 
also being present. 
It seems striking that while our studies on B-LHa 
demonstrated sequence variability, no such phenom- 
enon was encountered uring the elucidation of  
B-LHfl structure. Particularly, no amino acid sequence 
variability was observed around the carbohydrate 
attachment site. Both tryptic glycopeptides T2 and 
T2b , resulting from specific and non-specific leavages, 
have agreeing sequences with a sugar composit ion 
identical in both cases to that of the entire B-LH/3 
molecule. As seen in table 3, the polysaccharide unit 
of B-LH/3 differs from that of  O-LHfl [6]. This ap- 
pears to be the major specific difference in the struc- 
tures of  the ovine and bovine LH/3 subunits. 
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